Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia

Fludarabine (flu) -containing regimens such as flu, cyclophosphamide and rituximab have been established as one of the standard first line therapy in medically-fit chronic lymphocytic leukemia (CLL) patients. Therefore, flu-refractory (primary flu-insensitivity or flu-caused relapse) remains a major...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chunfa, Tu, Yifan, Freter, Carl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145702/
https://www.ncbi.nlm.nih.gov/pubmed/30237856
http://dx.doi.org/10.18632/oncotarget.26043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145702/
https://www.ncbi.nlm.nih.gov/pubmed/30237856
http://dx.doi.org/10.18632/oncotarget.26043

Ejemplares similares